BioAge Labs (BIOA) Change in Acquisitions & Divestments (2025 - 2026)
BioAge Labs' (BIOA) quarterly Change in Acquisitions & Divestments came in at $39.6 million in Q2 2026, up 365.82% year-over-year from $8.5 million in Q2 2025, and up 18.24% quarter-over-quarter from $33.5 million in Q1 2026.
Powered by 
Analysis
BioAge Labs (BIOA) Change in Acquisitions & Divestments (2025 - 2026) Analysis & Trends
BioAge Labs has disclosed Change in Acquisitions & Divestments across 2 years of filings, most recently posting $39.6 million for Q2 2026.
- In Q2 2026, Change in Acquisitions & Divestments rose 365.82% year-over-year to $39.6 million; the TTM figure through Jun 2026 stood at $124.8 million (up 1368.61% YoY), while the FY2025 annual figure was $60.2 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments came in at $39.6 million for Q2 2026 at BioAge Labs, up from $33.5 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $39.6 million in Q2 2026 to a low of $8.5 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioAge Labs | 439.00 Mn | 439.00 Mn | -14.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.60 Mn |
| Mar 31, 2026 | 33.49 Mn |
| Dec 31, 2025 | 26.00 Mn |
| Sep 30, 2025 | 25.75 Mn |
| Jun 30, 2025 | 8.50 Mn |